← Back to Search

Behavioural Intervention

Art Therapy for Children with Cancer

N/A
Recruiting
Led By Jennifer L Raybin
Research Sponsored by OHSU Knight Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months
Awards & highlights

Summary

This trial aims to see if activities like drawing, painting, and making sculptures can help improve the quality of life and reduce symptoms in children with cancer, compared to just watching videos. These creative arts interventions

Who is the study for?
This trial is for children with cancer who can participate in creative arts like drawing, painting, and sculpting. It aims to see if these activities improve their quality of life during hospital stays. Children must be able to engage in the art activities and complete surveys.
What is being tested?
The CREATe Trial is testing whether art therapy (drawing, painting, making sculptures) or watching videos helps reduce symptoms and improves the well-being of children with cancer. The study compares creative arts against media interventions through discussions and surveys.
What are the potential side effects?
Since this trial involves non-invasive therapies such as art creation and video watching, there are minimal expected side effects. However, emotional distress from discussing illness or fatigue from participation could occur.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants that complete all interventions and data collection time points
Secondary outcome measures
Comparison of scores on the Faces between intervention arms
Comparison of scores on the PRO-CTCAE between intervention arms
Comparison of scores on the PROMIS between intervention arms
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Phase II arm I (CrA)Experimental Treatment2 Interventions
Patients participate in CrA interventions comprising drawing, painting, and making sculptures with a trained artist for 30 minutes once a week for 4 sessions over 12 weeks.
Group II: Phase II arm II (watch videos)Active Control2 Interventions
Patients passively watch videos for 30 minutes once a week for 4 sessions over 12 weeks.
Group III: Phase I (focus group)Active Control2 Interventions
Patients participate in focus groups to develop CrA intervention on study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Art Therapy
2016
Completed Phase 2
~750

Find a Location

Who is running the clinical trial?

OHSU Knight Cancer InstituteLead Sponsor
234 Previous Clinical Trials
2,088,555 Total Patients Enrolled
Oregon Health and Science UniversityOTHER
994 Previous Clinical Trials
7,386,876 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
846 Previous Clinical Trials
672,853 Total Patients Enrolled
~48 spots leftby Mar 2026